Is it safe to take Lexapro (escitalopram) 20 mg together with amitriptyline 50 mg?

Combining Lexapro 20mg and Amitriptyline 50mg: Safety Assessment

This combination can be used together with appropriate monitoring, but requires caution due to two primary risks: serotonin syndrome and QT interval prolongation/cardiac arrhythmias.

Key Safety Concerns

1. Serotonin Syndrome Risk

The FDA label for Lexapro explicitly warns that concomitant use with tricyclic antidepressants (including amitriptyline) increases the risk of serotonin syndrome 1. The label specifically instructs clinicians to:

• Monitor patients for signs and symptoms of serotonin syndrome, particularly during Lexapro initiation and dosage increases
• Consider discontinuation of either or both drugs if serotonin syndrome occurs 1

Clinical signs to watch for include:

• Agitation, confusion, restlessness
• Muscle rigidity, tremor, hyperreflexia, incoordination
• Hyperthermia, tachycardia, hypertension
• Nausea, vomiting, diarrhea

2. Cardiac Risks

Both medications carry cardiac concerns that are additive when combined:

Amitriptyline has documented risks of:

• QT interval prolongation
• Torsades de Pointes (TdP)
• AV-node conduction delays and AV block
• Increased risk of cardiac arrest (OR = 1.69) 2

Escitalopram carries:

• FDA-mandated dose restrictions due to QT prolongation
• Maximum dose of 20mg (which you're already at)
• Further dose reduction required in patients >60 years 2

The 2014 European Heart Journal guideline classifies both drugs as having QT-prolonging potential, with amitriptyline specifically noted for TdP risk 2.

Pharmacokinetic Interaction

Escitalopram inhibits CYP2D6, which can increase amitriptyline levels. The FDA label documents that escitalopram 20mg increased desipramine (a tricyclic) levels by 40% (Cmax) and 100% (AUC) 1. This means your amitriptyline 50mg may effectively function at higher concentrations, increasing both therapeutic and adverse effects.

Clinical Evidence Supporting Combined Use

Despite these warnings, real-world evidence demonstrates this combination can be used safely with monitoring:

• A 2004 study specifically evaluated amitriptyline combined with citalopram (escitalopram's parent compound) in patients with comorbid depression, migraine, and tension headaches. The combination produced substantial improvement without major serotonergic syndrome side effects 3

• A 2015 multicenter RCT used amitriptyline 50mg in functional dyspepsia patients, demonstrating safety at this dose 4

Practical Management Algorithm

If proceeding with this combination:

1. Baseline assessment:

   • Obtain ECG to assess QT interval (QTc >500ms is concerning)
   • Document baseline heart rate, blood pressure
   • Screen for other QT-prolonging medications
   • Assess for cardiac risk factors (age >60, heart disease, electrolyte abnormalities)

2. Patient education on serotonin syndrome symptoms (listed above)

3. Follow-up monitoring:

   • Close monitoring during first 2-4 weeks (highest risk period)
   • Consider repeat ECG at 1-2 weeks if cardiac risk factors present
   • Monitor for anticholinergic side effects (dry mouth, constipation, urinary retention, confusion)

4. Consider dose adjustment:

   • The amitriptyline 50mg dose may need reduction to 25mg given the CYP2D6 interaction
   • Escitalopram is already at maximum recommended dose

Common Pitfalls to Avoid

• Don't ignore cardiac history: Patients with pre-existing cardiac conduction abnormalities, heart failure, or recent MI should not receive this combination
• Don't combine with other serotonergic drugs without extreme caution (tramadol, triptans, other SSRIs/SNRIs)
• Don't use in elderly patients (>60 years) without dose reduction and enhanced monitoring
• Don't forget electrolytes: Hypokalemia and hypomagnesemia increase arrhythmia risk

Alternative Considerations

If the combination seems too risky for a particular patient, consider:

• Using escitalopram alone at current dose
• Switching to a non-serotonergic adjunct (e.g., mirtazapine, bupropion)
• Using amitriptyline at lower doses (10-25mg) for specific indications like neuropathic pain or insomnia 5

The combination is not contraindicated but requires informed decision-making, patient counseling, and appropriate monitoring protocols to minimize risks of serotonin syndrome and cardiac complications.